- Home
- CLMT vs INVA Comparison
CLMT vs INVA Comparison
Compare CLMT & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLMT | INVA |
|---|---|---|
| Founded | 1916 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2024 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CLMT | INVA |
|---|---|---|
| Price | $34.16 | $22.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $28.65 | ★ $32.80 |
| AVG Volume (30 Days) | ★ 845.7K | 495.0K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 85.39 | ★ 816.67 |
| EPS | N/A | ★ 3.30 |
| Revenue | ★ $4,137,100,000.00 | $217,217,000.00 |
| Revenue This Year | $3.94 | $8.95 |
| Revenue Next Year | $1.07 | $12.65 |
| P/E Ratio | ★ N/A | $7.01 |
| Revenue Growth | N/A | ★ 62.63 |
| 52 Week Low | $11.00 | $16.52 |
| 52 Week High | $36.94 | $25.15 |
Technical Indicators
Market Signals| Indicator | CLMT | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 61.11 | 46.33 |
| Support Level | $17.70 | $20.56 |
| Resistance Level | $36.94 | $24.45 |
| Average True Range (ATR) | 1.15 | 0.57 |
| MACD | 0.01 | -0.14 |
| Stochastic Oscillator | 93.32 | 15.48 |
Price Performance
Historical ComparisonAbout CLMT Calumet Specialty Products Partners L.P.
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.